HEADER VIRAL PROTEIN 19-AUG-25 9Q47 TITLE INFLUENZA D VIRUS MATRIX PROTEIN N-TERMINAL DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX PROTEIN; COMPND 3 CHAIN: B, C, D, A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA D VIRUS; SOURCE 3 ORGANISM_TAXID: 1511084; SOURCE 4 GENE: P42; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS INFLUENZA VIRUS, MATRIX PROTEIN, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.T.LU REVDAT 1 26-AUG-26 9Q47 0 JRNL AUTH L.XIAOTONG JRNL TITL INFLUENZA D VIRUS MATRIX PROTEIN STRUCTURE REVEALS THE JRNL TITL 2 DOMAIN INVOLVED IN MEMBRANE AND VRNPS ASSOCIATION. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.83 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 3 NUMBER OF REFLECTIONS : 24654 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.770 REMARK 3 FREE R VALUE TEST SET COUNT : 1916 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.8270 - 5.5341 0.99 1791 155 0.2262 0.2376 REMARK 3 2 5.5341 - 4.3949 0.95 1658 140 0.2244 0.2976 REMARK 3 3 4.3949 - 3.8400 0.97 1721 137 0.2019 0.2613 REMARK 3 4 3.8400 - 3.4892 0.98 1682 146 0.2234 0.2643 REMARK 3 5 3.4892 - 3.2393 0.99 1728 147 0.2359 0.2334 REMARK 3 6 3.2393 - 3.0484 0.98 1700 144 0.2500 0.2891 REMARK 3 7 3.0484 - 2.8958 0.97 1679 144 0.2387 0.2562 REMARK 3 8 2.8958 - 2.7698 0.97 1679 140 0.2342 0.2860 REMARK 3 9 2.7698 - 2.6632 0.93 1583 130 0.2450 0.3288 REMARK 3 10 2.6632 - 2.5713 0.85 1508 119 0.2606 0.3425 REMARK 3 11 2.5713 - 2.4909 0.91 1545 138 0.2524 0.3041 REMARK 3 12 2.4909 - 2.4197 0.90 1530 129 0.2537 0.3045 REMARK 3 13 2.4197 - 2.3560 0.87 1539 123 0.2572 0.2971 REMARK 3 14 2.3560 - 2.3000 0.80 1395 124 0.2747 0.3034 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4705 REMARK 3 ANGLE : 0.466 6270 REMARK 3 CHIRALITY : 0.033 677 REMARK 3 PLANARITY : 0.003 807 REMARK 3 DIHEDRAL : 12.343 2988 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9Q47 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-AUG-25. REMARK 100 THE DEPOSITION ID IS D_1000299165. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25786 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.54000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 20,000, 2% 1,4-DIOXANE, AND REMARK 280 0.1 M BICINE BUFFER AT PH 9.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 73.81850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.85600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 73.81850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.85600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH D 202 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS B -1 REMARK 465 MET B 0 REMARK 465 GLU B 156 REMARK 465 LYS B 157 REMARK 465 TYR B 158 REMARK 465 HIS B 159 REMARK 465 HIS B 160 REMARK 465 LYS B 161 REMARK 465 MET B 162 REMARK 465 SER B 163 REMARK 465 MET B 164 REMARK 465 PHE B 165 REMARK 465 GLY B 166 REMARK 465 SER B 167 REMARK 465 THR B 168 REMARK 465 ALA B 169 REMARK 465 HIS C -1 REMARK 465 MET C 0 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 GLN C 3 REMARK 465 ALA C 101 REMARK 465 GLY C 102 REMARK 465 ASP C 103 REMARK 465 LEU C 104 REMARK 465 THR C 105 REMARK 465 GLY C 106 REMARK 465 ILE C 107 REMARK 465 LYS C 108 REMARK 465 GLU C 109 REMARK 465 MET C 110 REMARK 465 MET C 111 REMARK 465 MET C 112 REMARK 465 MET C 113 REMARK 465 TYR C 114 REMARK 465 GLU C 115 REMARK 465 SER C 155 REMARK 465 GLU C 156 REMARK 465 LYS C 157 REMARK 465 TYR C 158 REMARK 465 HIS C 159 REMARK 465 HIS C 160 REMARK 465 LYS C 161 REMARK 465 MET C 162 REMARK 465 SER C 163 REMARK 465 MET C 164 REMARK 465 PHE C 165 REMARK 465 GLY C 166 REMARK 465 SER C 167 REMARK 465 THR C 168 REMARK 465 ALA C 169 REMARK 465 HIS D -1 REMARK 465 MET D 0 REMARK 465 LYS D 153 REMARK 465 ARG D 154 REMARK 465 SER D 155 REMARK 465 GLU D 156 REMARK 465 LYS D 157 REMARK 465 TYR D 158 REMARK 465 HIS D 159 REMARK 465 HIS D 160 REMARK 465 LYS D 161 REMARK 465 MET D 162 REMARK 465 SER D 163 REMARK 465 MET D 164 REMARK 465 PHE D 165 REMARK 465 GLY D 166 REMARK 465 SER D 167 REMARK 465 THR D 168 REMARK 465 ALA D 169 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 465 GLU A 156 REMARK 465 LYS A 157 REMARK 465 TYR A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 LYS A 161 REMARK 465 MET A 162 REMARK 465 SER A 163 REMARK 465 MET A 164 REMARK 465 PHE A 165 REMARK 465 GLY A 166 REMARK 465 SER A 167 REMARK 465 THR A 168 REMARK 465 ALA A 169 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG B 117 -169.93 -102.07 REMARK 500 LEU C 98 44.13 -82.94 REMARK 500 TYR A 114 -4.77 66.72 REMARK 500 REMARK 500 REMARK: NULL DBREF1 9Q47 B 1 169 UNP A0A7D5AIJ2_9ORTO DBREF2 9Q47 B A0A7D5AIJ2 1 169 DBREF1 9Q47 C 1 169 UNP A0A7D5AIJ2_9ORTO DBREF2 9Q47 C A0A7D5AIJ2 1 169 DBREF1 9Q47 D 1 169 UNP A0A7D5AIJ2_9ORTO DBREF2 9Q47 D A0A7D5AIJ2 1 169 DBREF1 9Q47 A 1 169 UNP A0A7D5AIJ2_9ORTO DBREF2 9Q47 A A0A7D5AIJ2 1 169 SEQADV 9Q47 HIS B -1 UNP A0A7D5AIJ EXPRESSION TAG SEQADV 9Q47 MET B 0 UNP A0A7D5AIJ EXPRESSION TAG SEQADV 9Q47 HIS C -1 UNP A0A7D5AIJ EXPRESSION TAG SEQADV 9Q47 MET C 0 UNP A0A7D5AIJ EXPRESSION TAG SEQADV 9Q47 HIS D -1 UNP A0A7D5AIJ EXPRESSION TAG SEQADV 9Q47 MET D 0 UNP A0A7D5AIJ EXPRESSION TAG SEQADV 9Q47 HIS A -1 UNP A0A7D5AIJ EXPRESSION TAG SEQADV 9Q47 MET A 0 UNP A0A7D5AIJ EXPRESSION TAG SEQRES 1 B 171 HIS MET MET ALA GLN GLU GLN LEU LEU ALA GLU LEU GLU SEQRES 2 B 171 GLY TYR LEU ARG GLY VAL ASN PRO MET THR ARG GLN THR SEQRES 3 B 171 ILE MET LYS SER ALA ARG GLY GLY MET ASP SER ALA LYS SEQRES 4 B 171 GLU ALA ALA LYS ALA ALA LYS LYS GLY GLU MET GLN LEU SEQRES 5 B 171 THR SER GLY GLU SER ILE VAL VAL HIS ILE CYS LEU ARG SEQRES 6 B 171 ALA MET TYR PRO GLY ILE LYS PRO TRP SER GLU ALA LYS SEQRES 7 B 171 LYS ASP LEU ASP LYS ALA THR GLU GLY LEU SER GLY LYS SEQRES 8 B 171 ASP SER LYS ASN ILE ARG LYS ALA LEU ARG LYS ALA GLY SEQRES 9 B 171 ASP LEU THR GLY ILE LYS GLU MET MET MET MET TYR GLU SEQRES 10 B 171 MET ARG GLU ASP LYS LYS ALA GLU MET VAL GLU GLN ILE SEQRES 11 B 171 TYR ASP ASP PRO GLU ASP PHE THR GLU ASP VAL ARG LEU SEQRES 12 B 171 GLY THR VAL ALA ALA TRP LEU GLN CYS LYS ASN LYS ARG SEQRES 13 B 171 SER GLU LYS TYR HIS HIS LYS MET SER MET PHE GLY SER SEQRES 14 B 171 THR ALA SEQRES 1 C 171 HIS MET MET ALA GLN GLU GLN LEU LEU ALA GLU LEU GLU SEQRES 2 C 171 GLY TYR LEU ARG GLY VAL ASN PRO MET THR ARG GLN THR SEQRES 3 C 171 ILE MET LYS SER ALA ARG GLY GLY MET ASP SER ALA LYS SEQRES 4 C 171 GLU ALA ALA LYS ALA ALA LYS LYS GLY GLU MET GLN LEU SEQRES 5 C 171 THR SER GLY GLU SER ILE VAL VAL HIS ILE CYS LEU ARG SEQRES 6 C 171 ALA MET TYR PRO GLY ILE LYS PRO TRP SER GLU ALA LYS SEQRES 7 C 171 LYS ASP LEU ASP LYS ALA THR GLU GLY LEU SER GLY LYS SEQRES 8 C 171 ASP SER LYS ASN ILE ARG LYS ALA LEU ARG LYS ALA GLY SEQRES 9 C 171 ASP LEU THR GLY ILE LYS GLU MET MET MET MET TYR GLU SEQRES 10 C 171 MET ARG GLU ASP LYS LYS ALA GLU MET VAL GLU GLN ILE SEQRES 11 C 171 TYR ASP ASP PRO GLU ASP PHE THR GLU ASP VAL ARG LEU SEQRES 12 C 171 GLY THR VAL ALA ALA TRP LEU GLN CYS LYS ASN LYS ARG SEQRES 13 C 171 SER GLU LYS TYR HIS HIS LYS MET SER MET PHE GLY SER SEQRES 14 C 171 THR ALA SEQRES 1 D 171 HIS MET MET ALA GLN GLU GLN LEU LEU ALA GLU LEU GLU SEQRES 2 D 171 GLY TYR LEU ARG GLY VAL ASN PRO MET THR ARG GLN THR SEQRES 3 D 171 ILE MET LYS SER ALA ARG GLY GLY MET ASP SER ALA LYS SEQRES 4 D 171 GLU ALA ALA LYS ALA ALA LYS LYS GLY GLU MET GLN LEU SEQRES 5 D 171 THR SER GLY GLU SER ILE VAL VAL HIS ILE CYS LEU ARG SEQRES 6 D 171 ALA MET TYR PRO GLY ILE LYS PRO TRP SER GLU ALA LYS SEQRES 7 D 171 LYS ASP LEU ASP LYS ALA THR GLU GLY LEU SER GLY LYS SEQRES 8 D 171 ASP SER LYS ASN ILE ARG LYS ALA LEU ARG LYS ALA GLY SEQRES 9 D 171 ASP LEU THR GLY ILE LYS GLU MET MET MET MET TYR GLU SEQRES 10 D 171 MET ARG GLU ASP LYS LYS ALA GLU MET VAL GLU GLN ILE SEQRES 11 D 171 TYR ASP ASP PRO GLU ASP PHE THR GLU ASP VAL ARG LEU SEQRES 12 D 171 GLY THR VAL ALA ALA TRP LEU GLN CYS LYS ASN LYS ARG SEQRES 13 D 171 SER GLU LYS TYR HIS HIS LYS MET SER MET PHE GLY SER SEQRES 14 D 171 THR ALA SEQRES 1 A 171 HIS MET MET ALA GLN GLU GLN LEU LEU ALA GLU LEU GLU SEQRES 2 A 171 GLY TYR LEU ARG GLY VAL ASN PRO MET THR ARG GLN THR SEQRES 3 A 171 ILE MET LYS SER ALA ARG GLY GLY MET ASP SER ALA LYS SEQRES 4 A 171 GLU ALA ALA LYS ALA ALA LYS LYS GLY GLU MET GLN LEU SEQRES 5 A 171 THR SER GLY GLU SER ILE VAL VAL HIS ILE CYS LEU ARG SEQRES 6 A 171 ALA MET TYR PRO GLY ILE LYS PRO TRP SER GLU ALA LYS SEQRES 7 A 171 LYS ASP LEU ASP LYS ALA THR GLU GLY LEU SER GLY LYS SEQRES 8 A 171 ASP SER LYS ASN ILE ARG LYS ALA LEU ARG LYS ALA GLY SEQRES 9 A 171 ASP LEU THR GLY ILE LYS GLU MET MET MET MET TYR GLU SEQRES 10 A 171 MET ARG GLU ASP LYS LYS ALA GLU MET VAL GLU GLN ILE SEQRES 11 A 171 TYR ASP ASP PRO GLU ASP PHE THR GLU ASP VAL ARG LEU SEQRES 12 A 171 GLY THR VAL ALA ALA TRP LEU GLN CYS LYS ASN LYS ARG SEQRES 13 A 171 SER GLU LYS TYR HIS HIS LYS MET SER MET PHE GLY SER SEQRES 14 A 171 THR ALA FORMUL 5 HOH *63(H2 O) HELIX 1 AA1 MET B 1 LEU B 14 1 14 HELIX 2 AA2 ASN B 18 GLY B 31 1 14 HELIX 3 AA3 GLY B 32 LYS B 45 1 14 HELIX 4 AA4 THR B 51 TYR B 66 1 16 HELIX 5 AA5 TRP B 72 THR B 83 1 12 HELIX 6 AA6 SER B 87 ALA B 101 1 15 HELIX 7 AA7 ASP B 103 TYR B 114 1 12 HELIX 8 AA8 ARG B 117 ASP B 131 1 15 HELIX 9 AA9 PRO B 132 PHE B 135 5 4 HELIX 10 AB1 THR B 136 ARG B 154 1 19 HELIX 11 AB2 GLN C 5 ARG C 15 1 11 HELIX 12 AB3 ASN C 18 GLY C 31 1 14 HELIX 13 AB4 GLY C 32 LYS C 45 1 14 HELIX 14 AB5 THR C 51 TYR C 66 1 16 HELIX 15 AB6 TRP C 72 THR C 83 1 12 HELIX 16 AB7 SER C 87 LEU C 98 1 12 HELIX 17 AB8 ARG C 117 ASP C 131 1 15 HELIX 18 AB9 PRO C 132 PHE C 135 5 4 HELIX 19 AC1 THR C 136 ARG C 154 1 19 HELIX 20 AC2 ALA D 2 LEU D 14 1 13 HELIX 21 AC3 ASN D 18 GLY D 31 1 14 HELIX 22 AC4 GLY D 32 LYS D 45 1 14 HELIX 23 AC5 THR D 51 TYR D 66 1 16 HELIX 24 AC6 TRP D 72 THR D 83 1 12 HELIX 25 AC7 SER D 87 ALA D 101 1 15 HELIX 26 AC8 ASP D 103 MET D 112 1 10 HELIX 27 AC9 ARG D 117 ASP D 131 1 15 HELIX 28 AD1 PRO D 132 PHE D 135 5 4 HELIX 29 AD2 THR D 136 LYS D 151 1 16 HELIX 30 AD3 ALA A 2 LEU A 14 1 13 HELIX 31 AD4 ARG A 15 VAL A 17 5 3 HELIX 32 AD5 ASN A 18 GLY A 31 1 14 HELIX 33 AD6 GLY A 32 LYS A 45 1 14 HELIX 34 AD7 THR A 51 TYR A 66 1 16 HELIX 35 AD8 TRP A 72 THR A 83 1 12 HELIX 36 AD9 SER A 87 ALA A 101 1 15 HELIX 37 AE1 ASP A 103 MET A 112 1 10 HELIX 38 AE2 ARG A 117 ASP A 131 1 15 HELIX 39 AE3 PRO A 132 PHE A 135 5 4 HELIX 40 AE4 THR A 136 SER A 155 1 20 CRYST1 147.637 55.712 90.472 90.00 127.07 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006773 0.000000 0.005118 0.00000 SCALE2 0.000000 0.017949 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013853 0.00000 MASTER 343 0 0 40 0 0 0 6 4718 4 0 56 END